ENvue Medical, Inc.
FEED
$0.82
-$0.01-1.47%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -36.29% | -29.73% | 92.02% | -39.53% | 11.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.29% | -29.73% | 92.02% | -39.53% | 11.29% |
| Cost of Revenue | 7.93% | 323.60% | 119.34% | 35.99% | 155.25% |
| Gross Profit | -114.91% | -230.74% | 42.11% | -108.18% | -44.43% |
| SG&A Expenses | 88.53% | 149.88% | 159.37% | 224.48% | 52.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.69% | 118.96% | 120.58% | 199.80% | 93.22% |
| Operating Income | -100.38% | -167.15% | -131.65% | -489.91% | -226.06% |
| Income Before Tax | -104.04% | -830.65% | 154.77% | -471.49% | -219.62% |
| Income Tax Expenses | 120.00% | -8,480.00% | 1,066.67% | 1,450.00% | 114.29% |
| Earnings from Continuing Operations | -104.17% | -798.11% | 151.10% | -477.18% | -218.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -104.17% | -798.11% | 151.10% | -477.18% | -218.37% |
| EBIT | -100.38% | -167.15% | -131.65% | -489.91% | -226.06% |
| EBITDA | -90.51% | -148.32% | -105.15% | -436.30% | -223.00% |
| EPS Basic | 77.00% | 67.24% | 74.48% | 96.20% | -25.58% |
| Normalized Basic EPS | 96.12% | 94.84% | 118.18% | 70.22% | -26.07% |
| EPS Diluted | 77.00% | 67.24% | 74.48% | 96.20% | -25.58% |
| Normalized Diluted EPS | 96.12% | 94.84% | 118.18% | 70.22% | -26.07% |
| Average Basic Shares Outstanding | 5,153.99% | 2,805.80% | 206.24% | 1,815.42% | 153.44% |
| Average Diluted Shares Outstanding | 5,153.99% | 2,805.80% | 206.24% | 1,815.42% | 153.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |